FDA Drug Application (018891) for CATAPRES-TTS-2 by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number018891
Product Number002
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage0.2MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCATAPRES-TTS-2
Active IngredientCLONIDINE



Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.